Description
FROZEN DRUGS
First action · last action
2012-09-26 · 2012-09-26
Transactions
2
First transaction's obligation
$9,728
Base + all options value (sum of deltas)
$9,088
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE - OTHER
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-09-26+$9,728= $9,728
- Mod P000012012-09-26-$641= $9,088
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-09-26 | +$9,728 | $9,728 | FROZEN DRUGS |
| Mod P00001· CLOSE OUT | 2012-09-26 | −$641 | $9,088 | FROZEN DRUGS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI RSKLEFCZ6127)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626P0776 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $22,990 | FY2026 |
| 36C26226N0708 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $387,926 | FY2026 |
| 36C26226D0102 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C26026P0469 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $114,588 | FY2026 |
| 36C24826N0573 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $30,000 | FY2026 |
| 36C24826A0015 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6505 from 580-HOUSTON (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25613F0353 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 580-HOUSTON | $5,477 | FY2013 |
| VA25612P2546 | MCKESSON PLASMA AND BIOLOGICS LLC | 580-HOUSTON | $10,147 | FY2012 |
| VA25612F2494 | ACTELION PHARMACEUTICALS US, INC. | 580-HOUSTON | $4,293 | FY2012 |
| VA25612F2461 | RX TECHNOLOGY CORP. | 580-HOUSTON | $4,270 | FY2012 |
| VA25612P2433 | SOUTHERN SAFETY SALES, INC. | 580-HOUSTON | $5,005 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25612P2560_3600_-NONE-_-NONE- · retrieved 2026-09-26.